Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  3, Issue 2, May-Aug 2016, Pages 137-142
 

Original Article

Prevention of Post-Anaesthetic Shivering After General Anaesthesia, Ondansetron Verses Butorphanol, A Randomized Double-Blinded, Placebo-Controlled Study

Sujeet Rai*, Sandeep Sahu**, Apurva Agarwal***, Chitra****, Anil Verma***, H.D. Pandey****

*Assistant Professor, Department of Anesthesiology, Mahamaya Rajkiya Allopathic Medical college, Ambedkar Nagar. **Additional Professor, Department of Anesthesiology & Emergency Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences Luckn

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.3216.11

Abstract

 Background: Post­anesthetic shivering (PAS) is distressing for patients and may induce a variety of complications. The neurotransmitter pathways involved in the mechanism of post­anesthetic shivering are complex and poorly understood. We compared the effect of ondansetron ( 5­HT3 ntagonist) and butorphanol (agonist at “Kappa”­receptors and mixed agonist antagonist at mu opioid receptors) on intraoperative core and peripheral temperatures andPAS. Methods:After approval from institutional ethics committee and written informed consent 90 patients of age 18–60 years, ASA I­II, undergoing orthopedic, general or urological surgery were randomized into three groups.In this double­blinded, placebocontrolled, study: Group A(n = 30) received ondansetron 8 mg, Group B (n = 30) received Butorphanol, 25 gm / kg and Group C (n = 30) received saline 4 ml intravenous (IV) immediately before the anesthetic induction. Heart rate (HR), mean arterial pressure (MAP), oxygen saturation (SPO2), core (nasopharynx) and fingertip temperature (dorsum of middle finger) was recorded. Balanced general anaesthesia was induced by propofol 2.5 mg/kg and intubation was done with Vecuronium 0.1mg/kg. Anaesthesia was maintained with 70% N 2O in O2 and propofol infusion. PAS was documented by persons blinded to the study and included trainees in anesthesiology who were unaware of the group assignment. Results: PAS occurred in 19 of 30 (63.3%) patients in Group C (saline), compared with 6 of 30 (20%) in ondansetron group (P = 0.002) and 7 of 30 (23.3%) in butorphanol group (P = 0.004). Within each group, core temperature decreased and peripheral temperature increased significantly, but there were no significant differences among the groups A and B at any time interval. Conclusion: We conclude that both, ondansetron (8 mg) and butorphanol (25  gm / kg) IV given during the induction of anesthesia prevents PAS equally without affecting the core­to­peripheral redistribution of heat during general anesthesia. 

Keywords: Ondansetron; Butorphanol; Post­Anesthetic Shivering; General Anesthesia; Hypothermia.


Corresponding Author : Sandeep Sahu**